Skip to content

Medipore Tape Study

The Use of Wound Taping Protocol to Improve Cosmetic Scar After Anterior Cruciate Ligament (ACL) Reconstruction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02676115
Enrollment
60
Registered
2016-02-08
Start date
2015-02-28
Completion date
2016-02-29
Last updated
2016-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scarring

Keywords

Cosmetic Wound Healing, anterior cruciate ligament (ACL)

Brief summary

This is a prospective, single-blinded, two-arm, randomized, parallel, pragmatic, effectiveness trial that will enroll patients undergoing arthroscopic anterior cruciate ligament reconstruction in order to evaluate the efficacy of using Medipore tape to improve cosmetic wound healing and scaring.

Interventions

OTHERStandard Post Operative Skin Care

Control group subjects will receive the standard post-operative skin care which are steri-strips covered with gauze, and this will be removed at the first visit. No additional skin dressings will be used in the control group.

OTHERMedipore Tape

* One layer of Medipore tape will be placed across the incision. * Patients will be instructed on how to change the tape, and will be encouraged to change the tape as often as once per week for hygiene. When patients return to the office for their regularly scheduled visit, the Medipore tape will be changed and a picture of the scar will be taken.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
15 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* All patients undergoing arthroscopic ACL reconstruction with bone-patella-tendon-bone autograft at the Ambulatory Surgical Center and Hospital for Joint Diseases will be eligible for enrollment. * Patient is indicated for ACL reconstructive surgery with bone-patella-tendon-bone autograft

Exclusion criteria

* Subjects/Parents who are mentally impaired and are unable to give consent * Patients with prior vertical anterior knee incisions * Patients with known skin reactions to adhesive * Patients with high risk for abnormal scar formation and keloids

Design outcomes

Primary

MeasureTime frameDescription
Change in patients' own appraisal of their scar assessed quantitatively by change in Manchester Scar Scale (MSS) Score6 Months
Quantitative Assessment of Scar using Patient and Observer Scar Assessment Scale (POSAS)6 Months
Dermatology Life Quality Index (DLQI)6 MonthsQuantitative assessment of health-related quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026